Interestingly, the higher percentage of CD3+CD4+ cells bearing CD132 present in RA BM than in OA BM may explain why CD3+CD4+ cells from RA patients react stronger to IL-15 stimulation. The gene discussed is IL2RG; the disease is rheumatoid arthritis.